Venture Capital Investors

ArriVent Biopharma

ArriVent Biopharma is a venture capital investment firm that invests in technology-based companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Arrivent was founded in 2021 with a mission to globally develop top biopharma innovations from around the world to deliver important medicines to patients. Recognizing the plethora of potential first- and best-in-class candidates out of China and other geographic areas such as Europe, South Korea and Japan--and the risk that these might never make it to market due to development challenges in the areas in which they were discovered--we have made it our mission to ensure these innovations get into the hands of patients and physicians across the globe.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/27/2023

Transaction History

Our records indicate that ArriVent Biopharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

President

Stuart Lutzker

        

Chief Technology Officer

Yang Wang

        

Chief Executive Officer

Bing Yao

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

ArriVent Biopharma has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Arrington XRP Capital Fund | Arrow Venture Partners

Share this article

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary